• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL INSPIRE 8 HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL INSPIRE 8 HOLLOW FIBER OXYGENATOR; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Catalog Number 03703
Device Problem Increase in Pressure (1491)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/15/2021
Event Type  malfunction  
Manufacturer Narrative
Patient information was not provided the inspire 8 m start hollow fiber oxygenator is a non-sterile device assembled into a sterile convenience pack (item in00647, lot 2011090095) that is not distributed in the usa.The expiration date refers to the sterile finished product into which the oxygenator was assembled.As the sterile convenience pack is not distributed in usa, the udi number is not applicable.The complained inspire 8 start oxygenator is not distributed in the usa.The oxygenator inspire 8 start is similar to the oxygenator inspire 8 m (catalogue 050701), which is distributed in the usa, for which the device identifier is 08033178112260.Lot of the complained inspire 8 start oxygenator could not be identified.Possible lots are 2011030001 or 2011030001 or 2010160105 or 2010230.The complained inspire 8 start oxygenator is a non-sterile component assembled into a convenience pack that is not distributed in the usa.The stand alone inspire 8 start oxygenator is not distributed in the usa and is similar to the inspire 8 oxygenator (catalogue 050701) that is registered in the usa (510(k) number: k180448).The device manufacture date refers to manufacture date of the sterile, finished convenience pack into which the oxygenator was assembled.Sorin group (b)(4) manufactures the inspire 8 start m hollow fiber oxygenator.The incident occurred in (b)(6).A review of the dhr did not identify any deviations or non-conformities relevant to the reported issue.The involved device is not available for return to sorin group (b)(4) for investigation.Follow up with the customer clarified the following points: no oxygenation performance issue was reported.Blood flow rate pre-membrane was 5 lpm, post-membrane was 0.5 lpm the pump sheet of the procedure is not available the low pressure occurred at the starting surgery, after clamping and before declamping medical team elected to change out the oxygenator blood loss occurred during oxygenator change out.Prolonged procedure caused increased assistance in post declamping if any additional information pertinent to the reported event is obtained, it will be provided in a supplemental report.
 
Event Description
Sorin group (b)(4) has received a report of oxygenator low pressure during procedure.Surgery was prolonged of 30 minutes.There is not report of any patient injury.
 
Manufacturer Narrative
Verification of manufacturing records confirmed that noticed device was released as conform according to specifications.Analysis of complaints database revealed no other similar cases notified for batch concerned.Part was not made available for return, nor pump-sheet was provided to support the investigation.Based on information provided during follow up with the customer, livanova believes the most probable root cause of the reported hydraulic resistance to passage of blood exhibited by oxygenator was traced back to increase of the pressure drop across the unit, most likely due to undesired cellular activation of biological material inside circuit as a result of platelet adhesion and fibrin layer deposition in oxy fibers.High pressure excursion event across oxygenator is a multifactorial phenomenon possibly affected by interaction of multiple contributing factors such as clinical procedure (e.G.Surgical material), therapies (e.G.Anticoagulant prescription, heparin composition and priming composition) and patient-specific health conditions.The risk is in the acceptable region.No specific action is currently deemed necessary.Livanova will keep monitoring the market.
 
Event Description
See initial report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INSPIRE 8 HOLLOW FIBER OXYGENATOR
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
mirandola
Manufacturer (Section G)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
mirandola 41037
IT   41037
Manufacturer Contact
enrico greco
14401 w 65th way
arvada, CO 80004
MDR Report Key12802621
MDR Text Key283483343
Report Number9680841-2021-00031
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeTS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Remedial Action Other
Type of Report Initial,Followup
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/12/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/09/2023
Device Catalogue Number03703
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Was the Report Sent to FDA? No
Date Manufacturer Received12/24/2022
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/09/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age52 YR
Patient SexMale
Patient Weight75 KG
-
-